Schedule 13G ownership disclosure
PHIO PHARMACEUTICALS CORP
Common stock, par value $0.0001 per share · CUSIP: 71880W501
Event date: 2025-01-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mitchell P. Kopin
Shares: 530,171.00 · Class: 9.99%
- Daniel B. Asher
Shares: 530,171.00 · Class: 9.99%
- Intracoastal Capital LLC
Shares: 530,171.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-004657
- Form type
- SCHEDULE 13G
- Filer
- INTRACOASTAL CAPITAL, LLC
- CIK
- CIK 1646799
- Filed
- Jan 17, 2025
- Reporting period
- Jan 13, 2025
- Description
- Schedule 13G beneficial ownership